NCT01093560Unknown不适用
Fat Effects in Women With Metabolic Syndrome
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- Flow Mediated Dilation at 4 hours post feeding
研究概览
简要总结
Among 10 premenopausal women with Metabolic Syndrome:
Specific Aim 1: Compare the effects of acute fat feeding on flow mediated dilation (FMD) as measured by brachial artery reactivity among three fat challenges (saturated fat vs. monounsaturated fat (MUFA) vs. polyunsaturated fat (PUFA)at 4 hours post feeding. Hypothesis Saturated fat feeding will impair FMD but MUFA and PUFA feeding will not.
Specific Aim 2: Compare the effects of acute feeding on vascular inflammation as measured by VCAM and sICAM among three fat challenges at 3 1/2 hours post feeding.
Hypothesis: Saturated fat feeding will increase vascular inflammation but MUFA and PUFA will not.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •18-50 years of age,
- •Pre-menopausal,
- •Weight stable for at least 3 months,
- •Not planning to lose or gain weight for 3 months,
- •Meets the following 3/5 criteria for metabolic syndrome:
- •increased blood sugar
- •increased blood fats (triglycerides),
- •increased blood pressure,
- •decreased good cholesterol (HDL-C).
- •increased waist circumference,
排除标准
- •History of diabetes mellitus
- •Fasting glucose ≥ 126 mg/dL
- •History of cardiovascular disease (peripheral vascular disease, coronary artery disease, cerebrovascular disease)
- •Pregnant or planning a pregnancy within the study period
- •Fasting triglycerides > 500 mg/dL
- •Currently taking lipid lowering medications**
- •Oral or patch hormone contraception**
- •Currently taking vaso-active (blood pressure) medications**
- •SBP ≥ 140 and/or DBP ≥90 mm Hg or taking blood pressure lowering Rx
- •Chronic use of aspirin (prn use is allowed)
- •Chronic use of non-steroidal anti-inflammatory medications (prn use is allowed)
- •Tobacco use within 6 months of starting study
- •Participation in another clinical trial within the last 30 days
- •History of active gall bladder disease
- •History of digestive or malabsorptive disease requiring treatment or surgery
- •Moderate to severe lactose intolerance
- •Milk Allergy
- •Walnut Allergy or Nut Allergy
- •Coconut allergy
- •(**) Drugs within the following classifications are exclusionary: Lipid lowering, beta blockers, ACE inhibitors, angiotensin receptor blockers, diuretics, calcium channel blockers, alpha blockers, nitrates, hormone contraception includes patch or oral hormone contraception (Hormone containing IUDs or vaginal rings are okay)
结局指标
主要结局
Flow Mediated Dilation at 4 hours post feeding
时间窗: four hours
4 hours
次要结局
- Adhesion molecules (VCAM and sICAM)(3 1/2 hours)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
In Vitro Fertilization Outcomes in Metabolic SyndromeMetabolic SyndromeNCT01958424Meir Medical Center30
已完成
不适用
The Relation Between Adiposity, Inflammation, Glycaemia and Iron AbsorptionIron AbsorptionNCT03310203American University of Beirut Medical Center126
招募中
不适用
The effect of metabolic syndrome and associated genetic factors on fatty liver diseaseon alcoholic fatty liver diseaseJPRN-UMIN000027399Kyoto Prefectural University of Medicine3,000
已完成
不适用
Metabolism of Obese Women Under Exercise and Recovery HypoxiaObesityNCT05380830University of Sao Paulo45
已完成
不适用
Omentectomy and Metabolic SyndromeMetabolic SyndromeMorbid ObesityNCT00923260Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran24